(Q51804977)

12 April 2018

title

Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. (English)

1 reference

12 April 2018

author

Anssi Auvinen

4

1 reference

12 April 2018

Tiina Salminen

2

object named as

Tiina Salminen

1 reference

12 April 2018

3

Jani Raitanen

1 reference

12 April 2018

author name string

Katariina Korhonen

1

1 reference

12 April 2018

Jorma Isola

5

1 reference

12 April 2018

Hannu Haapasalo

6

1 reference

12 April 2018

publication date

13 May 2006

1 reference

12 April 2018

Journal of Neuro-Oncology

published in

1 reference

12 April 2018

volume

80

1 reference

12 April 2018

issue

1

1 reference

12 April 2018

page(s)

1-7

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1007/s11060-006-9146-9

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS11060-006-9146-9

Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-006-9146-9

Incidental meningiomas in autopsy study

21 January 2018

1 reference

12 December 2020

Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features.

1 reference

12 December 2020

Progestin and estrogen receptors in human meningioma

1 reference

12 December 2020

Progesterone and estrogen receptors in meningiomas: prognostic considerations.

1 reference

12 December 2020

The new WHO classification of brain tumours

1 reference

12 December 2020

Immunocytochemical study of progesterone receptor in human meningioma

1 reference

12 December 2020

Progesterone receptor expression in meningiomas.

1 reference

12 December 2020

Androgen receptor expression in meningiomas

1 reference

12 December 2020

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

12 December 2020

Mifepristone (RU 486) treatment of meningiomas

1 reference

12 December 2020

Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas

1 reference

12 December 2020

Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival

1 reference

12 December 2020

Progesterone and glucocorticoid receptor activation in meningiomas.

1 reference

12 December 2020

Incidences of gliomas and meningiomas in Denmark, 1943 to 1997.

1 reference

12 December 2020

The relapsing course of certain meningiomas in relation to pregnancy and menstruation

1 reference

12 December 2020

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

1 reference

12 December 2020

The prognostic value of progesterone receptor status in meningiomas

1 reference

12 December 2020

Hormonal dependency of cerebral meningiomas. Part 2: In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas

1 reference

12 December 2020

Sex steroid hormone exposures and risk for meningioma

1 reference

12 December 2020

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study

1 reference

12 December 2020

Expression of androgen and progesterone receptors in primary human meningiomas.

1 reference

12 December 2020

Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas

1 reference

12 December 2020

Recurrence of meningiomas after operation

1 reference

12 December 2020

Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas

1 reference

12 December 2020

Meningioma: proliferating potential and clinicoradiological features.

1 reference

12 December 2020

Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas

1 reference

12 December 2020

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

12 December 2020

Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo

1 reference

12 December 2020

The natural history of incidental meningiomas.

1 reference

12 December 2020

Hormonal manipulation of meningiomas in vitro

1 reference

12 December 2020

Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas.

1 reference

12 December 2020

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

12 December 2020

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.

1 reference

12 December 2020

Regulation of epidermal growth factor and insulin-like growth factor I receptors by estradiol and progesterone in normal and neoplastic endometrial cell cultures

1 reference

12 December 2020

Regression of a presumed meningioma with the antiestrogen agent mepitiostane

1 reference

12 December 2020

The association between breast carcinoma and meningioma in women

1 reference

12 December 2020

Breast cancer and meningioma

1 reference

12 December 2020

Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data

1 reference

12 December 2020

Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas

1 reference

12 December 2020

MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.

1 reference

12 December 2020

Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy

1 reference

12 December 2020

MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas.

1 reference

12 December 2020

Antiestrogenic therapy of meningiomas--a pilot study.

1 reference

12 December 2020

Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas

1 reference

12 December 2020

The molecular biology of hormone and growth factor receptors in meningiomas

1 reference

12 December 2020

Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?

1 reference

12 December 2020

Interdependence of epidermal growth factor and insulin-like growth factor-I expression in the mouse uterus

1 reference

12 December 2020

Hormone receptors in initially excised versus recurrent intracranial meningiomas

1 reference

12 December 2020

Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation

1 reference

12 December 2020

Expression of estrogen receptors alpha and beta in human meningiomas.

1 reference

12 December 2020

10.1007/S11060-006-9146-9

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

16703453

1 reference

12 April 2018